Pfizer Prevnar 13 Pneumococcal Vaccine

Prevnar 13 is a 13-valent pneumococcal conjugate vaccine used to prevent invasive disease caused by Streptococcus pneumoniae in infants and adults. It contains purified capsular polysaccharides conjugated to a carrier protein, qualifying as an immunological product under HTS 3002.15.00 due to its measured doses packaged for retail sale in pre-filled syringes.

Import Duty Rates by Country of Origin

Origin CountryMFN RateCh.99 SurchargesTotal Effective Rate
πŸ‡¨πŸ‡³ChinaFreeβ€”Free
πŸ‡²πŸ‡½MexicoFreeβ€”Free
πŸ‡¨πŸ‡¦CanadaFreeβ€”Free
πŸ‡©πŸ‡ͺGermanyFreeβ€”Free
πŸ‡―πŸ‡΅JapanFreeβ€”Free

More Specific Codes

This product may fall under a more specific subheading:

Alternative Classifications

This product could be classified differently depending on its characteristics or intended use.

3002Same rate: Free

If containing yeasts or antigens of microorganisms

Products with yeast cultures or microbial antigens shift to vaccines/toxins heading.

3002.12.00Same rate: Free

If antisera or other blood fractions

Antisera like immune globulins are classified separately from conjugate vaccines.

3004.90Higher: 10% vs Free

If not put up in measured doses for retail

Bulk immunological products without retail packing fall under medicaments heading.

Not sure which classification is right?

Our AI classifier can analyze your specific product and recommend the correct HTS code with confidence.

Import Tips & Compliance

β€’ Obtain FDA approval and biologics license; ensure cold chain documentation for vaccines

β€’ Provide certificates of analysis confirming immunological activity and sterility

β€’ Avoid misclassification as unmixed antigens by verifying retail packaging and measured doses